SEATTLE â" June 16, 2008 â" Patients with advanced non-small cell lung cancer treated with a newer targeted drug (cetuximab) used in a combination chemotherapy regimen survived slightly longer than patients treated with the combination chemotherapy alone, a new study shows.
By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.
Thursday, June 19, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment